They may directly kill tumor cells, or they can promote CD8+ T cell recruitment and activation by elaborating T cell-attracting chemokines such as CXCL9 and CXCL10, and Th1 cytokines such as IL-12 [134,135,136,137]. This evidence concerns the gene CXCL9 and neoplasm.